Knuckle pads

M13_KNUCKLEPADS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M72.1 Cause of death: ICD-10 — M72.1 2 out of 7 registries used, show all original rules.	59
4. Check minimum number of events None	59
5. Include endpoints None	59
6. Filter based on genotype QC (FinnGen only)	59

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M72

NAME	M13_KNUCKLEPADS
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M721
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M721
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Knuckle pads based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	435	219	216
Only index persons	400	203	197
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	-	54.15	51.83
Only index persons	52.14	53.44	50.80

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	59	28	31
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	55.75	52.08	59.06

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
53: Matched controls
529

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M72.1

ICD-10 Finland

Knuckle pads

+∞

75.9

NDM10

NOMESCO Finland

Palmar fasciotomy of hand

+∞

13.0

M75.1

ICD-10 Finland

Rotator cuff syndrome

10.4

10.9

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

53.1

8.0

N02AX02

ATC

tramadol; systemic, rectal

5.5

7.9

138

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

5.1

7.2

101

M54.5

ICD-10 Finland

Low back pain

5.0

6.9

J01DA01

ATC

[U] cefalexin; systemic

4.8

6.0

235

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019198) Lymphocytes [#/volume] in Blood

201

3.25

4.60

4.6

6.3

1.8

1.7

e9/l

0.33

177

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4.17

4.51

3.6

1.9

50.3

34.1

u/l

0.54

(3006315) Basophils [#/volume] in Blood

194

3.19

4.51

4.6

6.3

0.1

0.0

e9/l

2.09

162

(3013115) Eosinophils [#/volume] in Blood

203

3.21

4.48

4.6

7.3

0.2

e9/l

0.44

175

(3001604) Monocytes [#/volume] in Blood

193

3.00

4.09

4.7

6.4

0.6

e9/l

0.15

160

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

101

3.09

4.02

2.9

1.9

2.4

3.2

mg/l

1.14

(3013650) Neutrophils [#/volume] in Blood by Automated count

259

3.16

3.96

5.2

12.0

4.4

e9/l

0.08

217

(42870588) Differential panel, method unspecified - Blood

140

2.90

3.86

4.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3.21

3.73

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3.51

3.59

2.1

4.3

237.1

263.4

u/l

0.38

(3018095) Leukocytes [#/volume] in Urine

179

2.72

3.48

4.8

3.4

84.5

80.9

e6/l

0.02

122

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3.43

3.47

1.7

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3.36

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

274

2.63

2.92

6.4

4.8

6.4

6.8

mmol/l

0.83

253

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

183

2.46

2.87

2.6

1.9

90.6

92.1

pmol/l

0.06

(3023368) Bacteria identified in Blood by Culture

126

2.53

2.85

3.6

3.9

—

(3011288) Drugs identified in Urine by Screen method

8.95

2.80

2.6

1.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

179

2.38

2.67

3.6

2.9

—

(40768797) Stomach Pathology biopsy report

2.86

2.48

1.0

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2.75

2.44

4.4

2.1

2.4

g/l

0.02

(3021589) Normoblasts [#/volume] in Blood

212

2.26

2.40

8.9

9.9

0.0

e9/l

0.71

169

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.56

2.35

3.1

2.9

5.5

2.2

e6/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

311

2.41

2.33

7.1

3.9

—

(36304419) Bacteria [Presence] in Urine

137

2.27

2.29

4.0

2.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2.65

2.29

4.6

2.1

12.7

12.4

umol/l

0.07

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

207

2.19

2.25

5.0

4.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2.76

2.19

1.9

2.4

1.5

1.7

0.33

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.37

2.04

3.0

2.7

0.5

1.7

e6/l

—

(3026008) Bacteria identified in Urine by Culture

152

2.12

2.00

6.5

3.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3.47

1.95

2.7

2.0

—

(3049717) Cytology report of Urine Cyto stain

3.80

1.89

2.3

3.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

326

2.18

1.87

4.3

3.7

13.9

12.3

mm/h

0.25

291

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

4.44

1.86

3.4

1.8

—

(3019060) Gas panel - Arterial blood

2.92

1.80

6.0

3.9

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

212

1.97

1.75

8.4

3.7

34.9

35.4

g/l

0.14

199

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

111

2.05

1.65

3.0

2.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.08

1.60

3.2

3.1

30.0

100.2

ng/l

0.76

(3035350) Ketones [Presence] in Urine by Test strip

219

1.88

1.53

4.5

4.0

0.0

estimate

—

(3042936) Bacteria identified in Isolate by Culture

2.21

1.52

2.5

2.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2.26

1.51

3.0

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.70

1.50

8.1

10.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.92

1.47

1.0

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3.31

1.47

1.2

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

260

1.85

1.45

3.2

2.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

176

1.85

1.45

5.4

2.5

90.2

130.7

ug/l

0.96

162

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.00

1.40

0.0

1.5

—

(3000330) Specific gravity of Urine by Test strip

3.11

1.39

2.6

4.1

—

(3032080) INR in Blood by Coagulation assay

197

1.80

1.36

13.6

8.3

1.3

1.2

inr

0.06

(3019832) Treponema pallidum Ab [Presence] in Serum

2.27

1.24

2.5

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

221

1.73

1.21

6.1

5.2

0.0

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

158

1.75

1.18

2.5

2.2

—

(40758558) Short blood count panel - Blood

124

1.79

1.15

3.1

8.0

—

(3012544) pH of Venous blood

2.10

1.14

6.3

2.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

100

1.82

1.11

3.8

4.6

—

(3022145) Colonoscopy Study observation

2.07

1.09

1.2

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

226

1.67

1.09

4.6

3.9

0.0

estimate

—

(3022621) pH of Urine by Test strip

2.39

1.05

4.0

2.8

—

(1761868) Lipid panel - Serum or Plasma

177

0.53

1.03

2.9

2.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.94

1.02

3.4

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

487

2.28

1.01

24.0

15.9

3.9

4.0

mmol/l

0.30

468

(3019550) Sodium [Moles/volume] in Serum or Plasma

486

2.31

1.01

24.0

15.8

139.5

139.7

mmol/l

0.17

467

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.07

1.01

1.6

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2.36

0.96

2.5

2.1

0.6

0.1

e6/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1.77

0.95

2.4

5.4

—

(40768804) Tissue Pathology biopsy report

186

1.60

0.92

2.4

2.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

2.04

0.87

2.7

3.9

—

0.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.97

0.84

1.8

1.6

—

(3009343) pH of Capillary blood

1.97

0.84

5.7

3.2

—

7.4

—

(3015736) pH of Urine

172

1.55

0.81

4.0

—

(3000494) Fungus identified in Specimen by Culture

1.75

0.78

1.0

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

498

1.99

0.74

23.3

16.2

89.1

79.4

umol/l

0.43

498

(3002032) Base excess in Venous blood by calculation

1.80

0.73

7.0

2.7

2.9

2.1

mmol/l

—

(3002385) Erythrocyte distribution width [Ratio]

395

1.59

0.72

22.5

17.4

13.8

13.9

0.14

380

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.93

0.70

1.0

1.3

—

(3025159) Blasts/100 leukocytes in Blood

1.93

0.70

3.0

4.2

—

0.0

—

(3044889) 12 lead EKG panel

344

1.51

0.69

3.7

3.8

—

(3025941) Bacteria identified in Stool by Culture

1.79

0.65

1.0

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.68

0.63

15.5

4.3

1.1

1.0

mmol/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

134

1.49

0.63

3.9

4.6

15.6

20.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.73

0.63

2.4

1.7

—

(3017181) Myelocytes/100 leukocytes in Blood

1.85

0.61

2.7

3.7

—

0.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.79

0.60

2.3

2.0

—

(3013512) EKG study

137

1.45

0.56

3.8

4.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.55

0.52

1.3

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.49

0.48

4.0

1.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.67

0.44

17.2

11.2

94.3

93.2

—

(36660697) Celiac disease serology panel - Serum

1.61

0.43

1.0

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.49

0.42

4.0

1.8

—

(4010399)

1.56

0.42

1.8

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.56

0.42

1.0

4.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.6

—

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.6

—

0.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.42

0.0

3.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1.51

0.41

1.0

5.1

69.7

68.6

g/l

—

(3002256) Pathology report gross observation

1.45

0.41

1.6

1.3

—

(3000991) Gas panel - Venous blood

1.37

0.35

14.0

8.6

—

(40761536) Microorganisms panel - Urine sediment

1.37

0.35

6.3

3.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

102

1.35

0.33

1.5

1.4

1.3

1.4

mg/l

—

(3029937) Albumin [Presence] in Urine by Test strip

121

1.32

0.32

5.1

4.7

0.0

estimate

—

(3020682) Albumin/Creatinine [Ratio] in Urine

140

1.30

0.32

4.7

3.7

8.6

9.6

mg/mmol

0.04

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

103

1.34

0.31

2.5

1.9

455.7

412.0

pmol/l

0.26

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

229

1.24

0.29

10.0

5.6

1.2

mmol/l

0.40

200

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

172

1.25

0.27

2.4

4.2

48.0

42.5

ng/l

0.07

125

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

508

1.43

0.26

11.8

9.7

28.4

25.0

u/l

0.38

483

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.21

0.0

2.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.9

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

2.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

0.00

0.21

0.0

2.1

—

3.3

—

(4034850)

0.00

0.20

0.0

9.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1.28

0.20

1.2

1.6

2.1

2.9

g/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

180

1.17

0.16

4.2

4.8

2.0

1.9

ug/l

0.08

154

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.07

0.09

1.0

2.4

4.7

10.5

ug/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.05

0.09

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

427

0.94

0.01

22.4

15.1

40.0

39.4

0.20

299

(3041096) Erythrocytes [Presence] in Urine by Automated

124

1.06

0.01

5.8

3.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

173

0.98

0.00

4.9

4.3

—

(3003694) ABO and Rh group [Type] in Blood

126

1.04

0.00

1.8

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

126

1.04

0.00

1.8

1.6

1.1

1.4

mmol/l

1.28

(40761511) CBC panel - Blood by Automated count

497

1.04

0.00

17.0

12.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(4306422)

0.00

0.0

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

110.2

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

3.6

—

108.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

1.1

—

66.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.7

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.0

1.2

—

55.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.0

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.00

0.00

3.6

9.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.88

0.00

5.0

3.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(4268621)

0.00

0.0

2.2

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.0

2.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.4

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

3.6

—

4.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.00

0.0

2.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.1

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

0.00

0.0

4.8

—

11.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

3.6

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

21.9

—

1831.3

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.0

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.0

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.0

1.5

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(44790047)

0.00

0.0

2.0

—

(44790049)

0.00

0.0

2.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

107.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

0.0

1.4

—

6.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(44806118)

0.00

0.0

2.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.3

—

9.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.0

1.0

—

90.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

1.7

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.2

—

(44790048)

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_KNUCKLEPADS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_KNUCKLEPADS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: M13_KNUCKLEPADS – Knuckle pads

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Knuckle pads

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints